MEDVi vs Trimi Health: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
MEDVi beats Trimi Health overall, scoring 7.7/10 vs 4.2/10. Trimi Health is more affordable at $175/mo vs $179/mo. Choose MEDVi for users who want a low entry price with oral and injectable co. Choose Trimi Health for cash-pay patients who want the cheapest flat-price compounde.
A side-by-side look at MEDVi and Trimi Health to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
MEDVi
#20 of 52MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake, one of the broader compounded mixes among independent telehealth providers in 2026.
Visit MEDViTrimi Health
#50 of 52Telehealth platform for compounded semaglutide and tirzepatide. Weekly injections in vial-and-syringe format only, no pens, no oral option. Pricing is flat across all doses, with the consult and overnight shipping included. Prescriptions route through the Arora Health medical group (Dr. Sean Arora MD, medical director) and are filled by VialsRx and GreenwichRx, the same backend that powers Telos RX. Founded May 2024 per the site's own schema markup; no legal entity suffix or street address is disclosed.
Visit Trimi Health| Feature | MEDVi | Trimi Health |
|---|---|---|
| Our Score | 7.7/10 | 4.2/10 |
| Starting Price | $179/mo | $175/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want a low entry price with oral and injectable compounded options | Cash-pay patients who want the cheapest flat-price compounded semaglutide we track ($99/mo on the annual plan) and will accept a weak Trustpilot record plus no-pro-rating cancellation terms in exchange |
| Ranking | #20 | #50 |
| Get started | Visit MEDVi | Visit Trimi Health |
Pros & Cons Compared
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only, no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Trimi Health
Pros
- +Flat pricing across all doses, your monthly price does not rise as your dose titrates up
- +$99/mo compounded semaglutide on the annual plan (billed $1,188 once yearly) is among the cheapest flat recurring rates we track; tirzepatide annual is $125/mo ($1,500 yearly)
- +Consult and overnight shipping included in the plan price, no add-on fees; HSA/FSA accepted, Klarna and Affirm financing available
- +Named medical director, Dr. Sean Arora MD of the Arora Health medical group, most compounded-only platforms name no one
- +Compounding pharmacies named: VialsRx (TX license #35264, site-claimed) and GreenwichRx, most competitors do not name theirs
- +Available in all 50 states plus DC per trytrimi.com/states
- +6-month money-back weight-loss promise published (conditions apply, read them before counting on it)
Cons
- −Trustpilot FELL from 4.6 earlier in 2026 to 3.4 across 71 reviews, ranking #62 of 70 in its category, recurring complaints cite account closures and withheld refunds
- −Once a prescription is signed, payments are final, no pro-rating, cancelling an annual plan mid-year forfeits the remainder. Full refund is available only BEFORE the prescription is signed
- −No legal entity disclosed, the site identifies only 'Trimi Health' with no LLC/Inc suffix and no street address (New York appears only in the site's schema markup)
- −Vial-and-syringe format only, no autoinjector pens, no oral option, no brand-name medications
- −LegitScript certification claimed but we could not verify it against LegitScript's registry
- −Mandatory arbitration clause in the terms
- −Retatrutide and orforglipron are listed as 'Preparing', roadmap items, not available today, do not enroll expecting them
- −Shares its medical group (Arora Health) and pharmacy (VialsRx) with Telos RX, a white-label backend relationship neither brand discloses on its own site
Our Verdict
MEDVi edges out Trimi Health with a score of 7.7/10 vs 4.2/10. If budget is your priority, Trimi Health starts at $175/mo compared to MEDVi's $179/mo. MEDVi offers both brand-name and compounded medications, giving you more flexibility. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose Trimi Health if you want: cash-pay patients who want the cheapest flat-price compounded semaglutide we track ($99/mo on the annual plan) and will accept a weak trustpilot record plus no-pro-rating cancellation terms in exchange.
Still undecided? Editor's #1 Overall Pick
TrimRx
$149/mo · 7.8/10 · Compounded
If neither MEDVi nor Trimi Health feels like the right fit, our overall #1 pick across all 52 GLP-1 telehealth providers is TrimRx, strongest balance of clinical oversight, transparent pricing, and verified availability.
Read Full Reviews
Related comparisons
Other matchups readers comparing MEDVi or Trimi Health tend to look at next.
- MEDVi vs Shed$199/mo
- MEDVi vs Hers$199/mo
- MEDVi vs Henry Meds$199/mo
- Trimi Health vs TrimRx$149/mo
- Trimi Health vs Strut Health$149/mo
- Trimi Health vs Maximus$150/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.